ADVANCED SYNOVIAL SARCOMA

Clinical trials for ADVANCED SYNOVIAL SARCOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SYNOVIAL SARCOMA trials appear

Sign up with your email to follow new studies for ADVANCED SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Engineered immune cells take aim at Hard-to-Treat cancers

Disease control Ongoing

This trial investigates a new type of immunotherapy for people with advanced cancers that carry a specific marker called NY-ESO-1. Researchers take a patient's own T cells, modify them in the lab to better recognize and attack cancer cells, and then infuse them back. The study al…

Matched conditions: ADVANCED SYNOVIAL SARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC

ADVANCED SYNOVIAL SARCOMA

Get alerted when new ADVANCED SYNOVIAL SARCOMA trials appear

Engineered immune cells take aim at Hard-to-Treat cancers